Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Official Says Baxter Failed To Cooperate In Heparin Probe

This article was originally published in PharmAsia News

Executive Summary

China's chief drug researcher accused Baxter International of failing to cooperate in an investigation of the source of China-made heparin. Jin Shaohong, deputy director of the China National Institute for the Control of Pharmaceutical and Biological Products, said Baxter would not supply test samples of its drug. Jin also said he does not believe the 81 U.S. deaths attributed to heparin were linked directly to the hypersulfated chondroitin sulfate made in China. U.S. officials say they have traced the problem heparin to Kaipu, a company in China. Jin noted two other users of Kaipu heparin experienced no ill effects. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068640

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel